Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome
- 11 July 2006
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 26 (9) , 842-849
- https://doi.org/10.1002/pd.1518
Abstract
Background Smith–Lemli–Opitz syndrome (SLOS) is a rare hereditary disorder of cholesterol metabolism. We examine the feasibility of identifying SLOS as a part of a routine prenatal screening and evaluate diagnostic testing in maternal urine (or serum), in addition to amniotic fluid. Methods Our SLOS risk algorithm utilized three Down syndrome screening markers (estimated 62% detection rate; 0.3% screen‐positive rate). Fifteen North American prenatal screening programs implemented this algorithm. Results SLOS risk was assigned to 1 079 301 pregnancies; 3083 were screen‐positive (0.29%). Explanations were found for 1174, including 914 existing fetal deaths. Among the remaining pregnancies, 739 were screen‐positive only for SLOS; 1170 were also screen‐positive for other fetal disorders. Five of six SLOS pregnancies (83%) were screen‐positive. All six had sonographic findings, were biochemically confirmed, and were terminated. Maternal urine steroid measurements were confirmatory in four cases tested. Second‐trimester prevalence among Caucasians was 1 in 101 000 (1 in 130 000 overall; no cases in other racial groups). Among 739 pregnancies screen‐positive only for SLOS, two cases were identified; another 69 had major fetal abnormalities. Conclusions Although SLOS occurred less often than previously reported, many other major abnormalities were detected. Implementing the algorithm as an adjunct to Down syndrome screening may be feasible. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: Utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriolAmerican Journal of Medical Genetics Part A, 2005
- Incidence of Smith-Lemli-Opitz syndrome in Canada: Results of three-year population surveillanceThe Journal of Pediatrics, 2004
- INBORNERRORS OFSTEROLBIOSYNTHESISAnnual Review of Genomics and Human Genetics, 2001
- Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.Journal of Medical Genetics, 1998
- Increased first trimester nuchal translucency as a prenatal manifestation of Smith‐Lemli‐Opitz syndromeAmerican Journal of Medical Genetics, 1995
- Smith‐Lemli‐Opitz syndrome: Prenatal diagnosis by quantification of cholesterol precursors in amniotic fluidAmerican Journal of Medical Genetics, 1995
- Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblastsClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterolsAmerican Journal of Medical Genetics, 1995
- Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz SyndromeNew England Journal of Medicine, 1994
- A newly recognized syndromeof multiple congenital anomaliesThe Journal of Pediatrics, 1964